about
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resourc...
Read More
106.04
-5.28
(-4.74%)
567.7K
XNYS Volume
XNYS 20 Jul, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Veradermics Inc took place on 20 Jul 2026, for the purpose of Veradermics Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Veradermics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..